Dr. Rick Klausner, Chief Medical Officer and SVP of Illumina, discusses how genomics will transform the future of oncology. In this short video Dr. Klausner describes two examples of how Illumina is helping to pave the way by partnering with pharmaceutical companies to create a 'Universal Oncology Test' and by initiating a consortium for setting new standards for oncology patient testing.